Dana Roque

Dana Roque is an Associate Professor at the University of Maryland School of Medicine within the Obstetrics, Gynecology and Reproductive Sciences department. She specializes in Gynecologic Oncology, focusing on chemotherapeutic and surgical treatments for cervical, uterine, ovarian, and other gynecologic malignancies, as well as complex surgeries for benign conditions. Her clinical practice utilizes open, laparoscopic, and robotic approaches across multiple hospitals.

• Education:
  • M.D., University of North Carolina at Chapel Hill School of Medicine (2002-2007)
  • B.S., Duke University in Chemistry (1998-2002)
  • Fellowship: Yale University in Gynecologic Oncology (2011-2014)
  • Residency: University of Pittsburgh Medical Center-Magee Womens Hospital in OB/GYN (2007-2011)

Dr. Roque's research interests span Molecular Oncology, Chemoresistance Mechanisms, and Targeted Therapies, particularly in Ovarian and Endometrial Cancers. Her work explores Tubulin Isotypes, Microtentacle Composition, and Novel Therapeutic Agents like HuR inhibitors and photodynamic therapies.

Recent research trends highlight her leadership in Clinical Trials for Platinum-Resistant Ovarian Cancer (e.g., NRG-GY0019, GOG 3018/OVAL) and HER2/Neu Amplified Endometrial Cancer (e.g., NRG-CC008). Translational studies focus on Tumor Microenvironment analysis, Molecular Profiling, and Robotic Surgery Simulation (TERPS program).

• Scientific Awards:
  • Baltimore Top Doctor (2019, 2020)

Dr. Roque holds multiple grants including NIH R01 funding for Photodynamic Priming in Ovarian Cancer, Foundation for Women's Cancer grants for Nanotechnology in Peritoneal Carcinomatosis, and departmental funding for HuR Inhibition Therapies. She serves on committees for the National Cancer Institute, Society of Gynecologic Oncology, and Foundation for Women's Cancer. Her lab work includes collaborations with Chiao-Huang Huang on photodynamic therapy and Jiayuh Lin on HuR inhibition.